or
forgot password

    • cancer clinical trials in springdale, AR

    • Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Non-small Cell Lung Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Lung Cancer
    Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Multiple Myeloma and Plasma Cell Neoplasm
    Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Breast Cancer
    Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Lung Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Breast Cancer, Metastatic Cancer
    1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Breast Cancer
    S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Lung Cancer
    Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Castrate-Resistant Prostate Cancer
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Prostate Cancer
    Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma, Follicular Grade 3 Lymphoma
    Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Stage IV Pancreatic Cancer
    Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Inoperable Locally Advanced Breast Cancer, Metastatic Breast Cancer (MBC)
    Single Arm on the Tolerability of Weekly Nab-paclitaxel
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Non Small Cell Lung Cancer (NSCLC)
    Adjuvant Chemotherapy in Patients With High Risk Stage I Non-squamous Non-Small Cell Lung Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Non-Small Cell Lung Cancer
    Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Prostatic Neoplasms
    Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
    Highlands Oncology Group, PA
    Springdale, Arkansas 72764
    Prostatic Neoplasms, Multiple Myeloma, Bladder Neoplasms, Lymphoma
    ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.
    For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.
    Springdale, Arkansas
    Lung Neoplasms
    An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Breast Neoplasms, Breast Cancer, Metastasis
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Lung Cancer
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Lung Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Pancreatic Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Non Small Cell Lung Carcinoma
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Non Small Cell Lung Carcinoma
    Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Breast Neoplasm
    DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Non-Small Cell Lung Cancer - Completely Resectable
    A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Small Cell Lung Cancer
    Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Small-Cell Lung Cancer
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Cachexia
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal
    Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Lung Cancer
    Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
    Highlands Oncology Group
    Springdale, Arkansas 72764
    First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis
    BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Endometrial Cancer